Capstone Investment Advisors, LLC Vertex Pharmaceuticals Inc Call Options Transaction History

Capstone Investment Advisors, LLC

$30.4 Billion
Q3 2024

Call Options

25 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$460.0 - $505.78 $552,000 - $606,936	1,200 Added 12.77%	10,600 $4.93 Million
Q2 2024 Aug 14, 2024	BUY	$392.81 - $485.53 $1.06 Million - $1.31 Million	2,700 Added 40.3%	9,400 $4.41 Million
Q1 2024 May 01, 2024	SELL	$407.69 - $446.08 $3.3 Million - $3.61 Million	-8,100 Reduced 54.73%	6,700 $2.8 Million
Q4 2023 Feb 12, 2024	BUY	$343.0 - $410.68 $1.13 Million - $1.36 Million	3,300 Added 28.7%	14,800 $6.02 Million
Q3 2023 Nov 13, 2023	BUY	$338.18 - $362.46 $1.01 Million - $1.09 Million	3,000 Added 35.29%	11,500 $4 Million
Q2 2023 Aug 10, 2023	BUY	$314.42 - $351.91 $282,978 - $316,719	900 Added 11.84%	8,500 $2.99 Million
Q1 2023 May 09, 2023	SELL	$283.23 - $323.1 $1.36 Million - $1.55 Million	-4,800 Reduced 38.71%	7,600 $2.39 Million
Q4 2022 Feb 10, 2023	BUY	$285.76 - $321.48 $200,032 - $225,036	700 Added 5.98%	12,400 $3.58 Million
Q3 2022 Nov 10, 2022	SELL	$273.83 - $305.53 $219,064 - $244,423	-800 Reduced 6.4%	11,700 $3.39 Million
Q2 2022 Aug 15, 2022	SELL	$234.96 - $292.55 $399,432 - $497,335	-1,700 Reduced 11.97%	12,500 $3.52 Million
Q1 2022 May 13, 2022	SELL	$221.42 - $260.97 $5.98 Million - $7.05 Million	-27,000 Reduced 65.53%	14,200 $3.71 Million
Q4 2021 Feb 11, 2022	SELL	$177.01 - $223.45 $1.06 Million - $1.34 Million	-6,000 Reduced 12.71%	41,200 $9.05 Million
Q3 2021 Nov 15, 2021	BUY	$181.39 - $202.99 $2.7 Million - $3.02 Million	14,900 Added 46.13%	47,200 $8.56 Million
Q2 2021 Aug 16, 2021	BUY	$187.49 - $221.1 $1.65 Million - $1.95 Million	8,800 Added 37.45%	32,300 $6.51 Million
Q1 2021 May 17, 2021	BUY	$207.02 - $241.31 $1.84 Million - $2.15 Million	8,900 Added 60.96%	23,500 $5.05 Million
Q4 2020 Feb 16, 2021	SELL	$207.01 - $276.09 $2.01 Million - $2.68 Million	-9,700 Reduced 39.92%	14,600 $3.45 Million
Q3 2020 Nov 16, 2020	BUY	$255.65 - $303.1 $1.15 Million - $1.36 Million	4,500 Added 22.73%	24,300 $6.61 Million
Q2 2020 Aug 14, 2020	BUY	$225.48 - $295.8 $1.29 Million - $1.69 Million	5,700 Added 40.43%	19,800 $5.75 Million
Q1 2020 May 15, 2020	SELL	$199.77 - $247.81 $7.03 Million - $8.72 Million	-35,200 Reduced 71.4%	14,100 $3.36 Million
Q4 2019 Feb 14, 2020	BUY	$166.71 - $223.91 $3.1 Million - $4.16 Million	18,600 Added 60.59%	49,300 $10.8 Million
Q3 2019 Nov 14, 2019	BUY	$166.23 - $187.09 $2.23 Million - $2.51 Million	13,400 Added 77.46%	30,700 $5.2 Million
Q2 2019 Aug 14, 2019	BUY	$164.61 - $190.37 $872,433 - $1.01 Million	5,300 Added 44.17%	17,300 $3.17 Million
Q1 2019 May 15, 2019	BUY	$163.73 - $194.7 $1.05 Million - $1.25 Million	6,400 Added 114.29%	12,000 $2.21 Million
Q4 2018 Feb 14, 2019	BUY	$151.91 - $192.21 $319,011 - $403,641	2,100 Added 60.0%	5,600 $928,000
Q3 2018 Nov 14, 2018	BUY	$167.73 - $192.74 $587,055 - $674,590	3,500 New	3,500 $675,000

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

Capital World Investors Los Angeles, CA

26.8M
Shares

$12.5 Billion
1.99% of portfolio
Vanguard Group Inc Valley Forge, PA

23.2M
Shares

$10.8 Billion
0.2% of portfolio
Black Rock Inc. New York, NY

21.3M
Shares

$9.9 Billion
0.23% of portfolio
State Street Corp Boston, MA

11.8M
Shares

$5.49 Billion
0.23% of portfolio
Capital Research Global Investors Los Angeles, CA

9M
Shares

$4.18 Billion
0.9% of portfolio

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capstone Investment Advisors, LLC with notifications on news.

Account